Fringe proteins are O-fucose-specific h-1,3 N-acetylglucosaminyltransferases that glycosylate the extracellular EGF repeats of Notch and enable Notch to be activated by the ligand Delta. In the sea urchin, signaling between Delta and Notch is known to be necessary for specification of secondary mesenchyme cells (SMCs). The Lytechinus variegatus Fringe homologue is expressed in both the signaling and receiving cells during this first Delta-Notch signal. Perturbation of Fringe expression through morpholino antisense oligonucleotide (MO) injection results in fewer SMCs but also causes decreased and delayed archenteron invagination. Partial endoderm specification occurs but expression of some endoderm genes is compromised. The data are consistent with a Fringe-requiring Notch signal as one upstream component of archenteron morphogenesis. Finally, Fringe perturbations result in more severe phenotypes than those previously reported for Notch dominant-negative (LvN neg ) injections or reported here for Notch MO (NMO) injections. Injecting a combination of LvN neg and NMO results in a more severe phenotype than either treatment alone, and this combination phenocopies the fringe MO embryos. Taken together, the results show that Fringe is necessary both for maternal and zygotic Notch signals, and these Notch signals affect specification of mesoderm and endoderm. D
Introduction
The Notch signaling pathway is important for the processes of cell specification and boundary formation throughout development in many organisms. Originally, identified and characterized in the wing disc of Drosophila melanogaster, Notch signaling has since been identified as essential for many aspects of development including axis formation, germ layer specification, organogenesis, and cellular differentiation Fehon et al., 1991; Jacobsen et al., 1998; Mello et al., 1994; Rones et al., 2000; Sherwood and McClay, 1999) . The Notch receptor is activated through interaction with a Delta, Serrate, or Lag-2 type ligand Rebay et al., 1991) , and this interaction leads to the cytoplasmic release of the Notch intracellular domain which translocates to the nucleus and acts as a transcription cofactor (Baron, 2003; Iso et al., 2003; Lai, 2002; Schroeter et al., 1998) .
Notch plays an early and central role in endomesoderm specification in the sea urchin McClay, 1999, 2001) . Vegetal blastomeres initiate endomesoderm specification at about 4th cleavage {Logan, 1999 #2157} {Oliveri, 2003 #3066}. Delta is expressed by micromeres at the vegetal pole shortly after the 6th cleavage. This expression is coincident with the experimentally timed reception of the Notch-activating ligand by veg2 cells, located just above the micromeres ( Fig. 1 ; McClay et al., 2000; Oliveri et al., 2002; Sweet et al., 1999; Sweet et al., 2002) . The first Delta-Notch signal results in specification of pigment cells and blastocoelar cells (Sweet et al., 2002) . Delta is expressed a second time, this time in the veg2 tier of cells, and this later expression results in specification of more blastocoelar cells and pharyngeal muscle. Presumably, this is a consequence of a second Delta-Notch signal between veg2 progeny (Sweet et al., 2002) . Delta continues to be present in veg2 progeny until the mesenchyme blastula stage, where it has the potential to signal across the SMC/ endoderm boundary Sherwood and McClay, 2001; Sweet et al., 2002) . Support for a possible Delta-Notch signal across the SMC/endoderm boundary currently is largely circumstantial. Antibody staining shows Delta on the SMC side of the boundary and Notch on the endoderm side (Sherwood and McClay, 1997; Sweet et al., 2002) . Injection of N act into one animal blastomere at the eight-cell stage results in an ectopic gut or increased contribution to the existing gut, suggesting that added Notch signaling augments endoderm (Sherwood and McClay, 2001) . Additionally, perturbation analyses showed that animal caps from embryos injected with N act develop into embryoids with differentiated endoderm, while control animal caps gave rise only to unspecified Dauer blastulae (Sweet et al., 2002) . While the underlying signaling and its consequences are not understood in detail relative to the endomesoderm gene regulatory network , it is clear that Notch signaling somehow impinges on endoderm specification.
From the above, it appears as though Notch signaling during sea urchin cleavage occurs in a cascade of activation events, beginning with the micromeres and continuing cellby-cell through the mesoderm, and perhaps into the endoderm McClay, 1999, 2001; Sweet et al., 2002) . The challenge is to parse out these sequential Notch signaling events to determine the function of each. One approach to meet this challenge is to examine modifiers of Notch signaling that are known to regulate Notch activation both spatially and temporally. Fringe is one such modifier that glycosylates extracellular EGF-like repeats on Notch, functioning as an O-fucose specific h-1,3 N-acetylglucosaminyltransferase (Haltiwanger and Stanley, 2002; Moloney et al., 2000) . Fringe glycosylation potentiates activation of Notch by Delta and blocks any Notch activation by Serrate (Fleming et al., 1997; Irvine and Wieschaus, 1994; Panin et al., 1997) . Thus, Fringe contributes to the spatial and temporal patterns of Notch activation signals by determining where each ligand can activate Notch.
Here, Lytechinus variegatus fringe is identified and its function studied to better understand the timing and role of Notch activation in germ layer specification. Fringe is required for activation of Notch during SMC specification. Fringe is also required for a Notch signal that directly or indirectly activates archenteron invagination while not appearing to disrupt expression of some genes in the endoderm gene regulatory network. The evidence also suggests a delay in oral-aboral ectoderm specification, most likely due to a delayed reception of required vegetal signals.
Materials and methods

Fringe cloning and sequence comparison
Degenerate primers were designed against peptides derived from ClustalX alignments (Chenna et al., 2003) to amino acid sequences from various Fringe homologues. A PCR product was obtained using degenerate primers on reverse transcribed RNA from multiple timepoints of L. variegatus development. The product was cloned into pGEM-T and sequenced by the Duke University Comprehensive Cancer Center DNA Analysis Facility (http:// www.cancer.duke.edu/dna/Sequencing).
Library screening and sequence analysis
A k-ZAP-II L. variegatus midgastrula cDNA library was screened with the product of degenerate primer PCR. The probe was 32 P-dCTP labeled with Rediprimer II random prime labeling kit (Amersham-Pharmacia Biotech). Screens were performed as previously described (Gross et al., 2003) . Positive clones were excised using ExAssist into pBS-II plasmids, which were transformed, purified, and sequenced. Fig. 1 . Overview of sea urchin morphogenesis and the role of Notch signaling. This panel represents development of the sea urchin embryo from the blastula stage through the midgastrula stage. Cells with an ectoderm fate are represented in blue, endoderm in yellow, and mesoderm in red. Maternal Notch (green) surrounds the blastula on the apical surface of all cells. Notch is lost from the vegetal plate after being activated there by Delta from the micromeres (arrows in blastula). The SMCs then express Delta in a broader pattern at the vegetal plate and presumably expand the cleared SMC region (arrows at mesenchyme blastula). At mesenchyme blastula, Notch is up-regulated on the apical surface of endoderm. Fringe is expressed by all cells of the embryo at the blastula stage, then it is lost first from the ingressed PMCs, and later Fringe is lost from the SMCs and finally from the endoderm as it invaginates.
Sequences were imported into Sequencher 4.1k (Gene Codes Corporation) and aligned into a complete contig. A single clone containing the entire open reading frame was subcloned.
The contig was translated and compared to known genes using blastx on the National Center for Biotechnology Information (NCBI) BLAST homepage. Representative fringe homologues were aligned with ClustalX (NCBI) and output in a Nexus format (Jeanmougin et al., 1998; Madden et al., 1996) . The alignment was imported into PAUP 4.0b and a consensus bootstrap analysis was done using neighbor joining with 1000 replicates. The tree was rooted with the invertebrate Fringe proteins. The sequences used for the phylogram were: L. variegatus Fringe ( 
Northern blot analysis and quantitative PCR
Approximately 3 mg of poly (A) mRNA isolated with Quickprep mRNA kit (Amersham-Pharmacia Biotech) was run on a 1% agarose/formaldehyde denaturing gel and transferred onto MagnaGraph using a Turboblotter System (Schleicher and Schuell). The blot was auto-irradiated in an UV Stratalinkerk 1800 (Stratagene). The blot was hybridized using standard molecular hybridization techniques with a 32 P-labeled 384-bp fragment of fringe (Church and Gilbert, 1984) . It was then stripped in 50% formamide, 6Â SSPE for 30 min at 658C and reprobed as above with a Lytechinus pictus ubiquitin fragment as a loading control (Gross et al., 2003) .
Quantitative PCR (QPCR) was performed basically as described (Amore et al., 2003) with the following modifications. Fringe primers were designed using the LightCycler Probe Design Software, Version 1.0 (Idaho Technology, Inc.). The primers showed a single peak following melting point analysis and a single band on agarose gel electrophoresis. The band was isolated and sequenced to verify that it was in fact fringe. The number of cycles required to cross a predetermined threshold (Ct) within the linear range of amplification was determined. The Ct for each injection sample was normalized to the Ct of ubiquitin for the same injection sample, which was run simultaneously [Ct NORM = Ct AVE (sample) À Ct AVE (ubiquitin)]. Two separate RT reactions were used and several reactions were averaged for each stage.
Antibody production and Western blot analysis
A recombinant plasmid was constructed to produce the mature Fringe protein with a 6X-His tag in the pQE32 plasmid (QIAexpressionist, Qiagen, Inc.). The plasmid was transformed into XL1-Blue bacterial cells, grown at 378C, and induced with IPTG as per the manufacturer protocol. The recombinant protein was found to be insoluble and was purified using the manufacturer protocol for insoluble proteins, with the addition of imidazole at 10 AM in all buffers. The isolated protein was dialyzed into PBS, at which time it immediately precipitated and was concentrated further through centrifugation. The slurry containing insoluble protein in PBS was used for the production of antibodies.
Recombinant Fringe protein slurry was used for injection into Guinea pigs, mice, and chickens (the latter at Aves Labs, Inc.). For Guinea pigs and mice, the insoluble protein slurry was mixed 1:1 with Freund's complete adjuvant and injected into three Guinea pigs and five mice (Charles River, Raleigh, NC). The schedule for Guinea pig and mice boosts were as described (Gross et al., 2003) . Two Guinea pigs and one mouse tested positive for reactivity to the purified recombinant protein. The two Guinea pigs were terminally bled 10 days after the final boost and the antiserum was frozen at À808C. Monoclonal antibodies were produced through fusion with NS-1 myeloma cells (Harlow and Lane, 1998; McClay and Wessel, 1984 ). An anti-Fringe antibody termed 1D12 was purified from total hybridoma supernatant using an Anti-Mouse IgM Monoclonal Antibody Affinity Isolation System (American Qualex). Chicken antiserum was isolated and the IgY fraction purified by Aves Labs, Inc. Two hens injected with the recombinant protein slurry produced viable antibodies, one of which was boosted additional times and an additional IgY fraction was purified.
Embryo fixation, staining, and confocal analysis
Embryos were reared to the desired timepoints in ASW at a constant temperature of either 258C or 188C. Fixation was for 15 min in either 2% paraformaldehyde/60%ASW or in 3.7% formaldehyde/60% ASW. All embryos were permeabilized with ice-cold 100% methanol for 1-2 min and washed into PBS with 5% normal goat serum (PBS/NGS). The embryos were washed three times for 15 min each in PBS/NGS before being placed into primary antibodies. Previously described antibodies were used at published dilutions: 1D5, EctoV, and Endo 1 (McClay and Wessel, 1984), SMC-1 (Sweet et al., 1999) , Guinea pig anti-Notch (Sherwood and McClay, 1997) , rabbit anti-SoxB1 (Kenny et al., 1999) , and Guinea pig anti-h-catenin (Miller and McClay, 1997) . The new chicken-anti-Fringe, Guinea pig anti-Fringe, and mouse monoclonal anti-Fringe were diluted to 1:500, 1:1000, and 1:5000 respectively. Primary antibodies were left on the embryos overnight at 48C. Washes were performed in triplicate for 15 min between primary and secondary antibody exposure. Cy2, Cy3, and Cy5 conjugated secondary antibodies were purchased from Jackson Immunochemicals, Inc. and diluted to 1:200. The secondary antibodies were left either at 258C for 1 h or overnight at 48C before being washed. Final washes were PBS/NGS three times for 15 min, followed by increasing concentrations of glycerol in PBS (10%, 30%, 50%) for 15 min per wash. Embryos were mounted in 50% glycerol under 0-thickness cover slips for confocal microscopy. Confocal images were gathered on a Zeiss 510 Confocal System, exported as a TIFF raw image series, analyzed, and stacked using Zeiss 410 software.
Injection of morpholino antisense oligonucleotide
Morpholino antisense oligonucleotides (MOs) were designed from primary sequence determinations (fringe), or from GenBank sequence (notch; NMO), by GeneTools, Inc. (Corvallis, OR). An MO (FMO) was produced beginning at the start site with the sequence 5V-GATGA-CTCGTTACATTGCGGAAAA-3V and was used for all reported analyses. Control MO (CMO) is the standard control MO designed against a mutated human splice site in the beta-globin pre-mRNA from thalassemic human reticulocytes (Stein et al., 1997; Summerton and Weller, 1997) .
CMO, NMO, and FMO were injected at various dilutions in 40% glycerol, 10% rhodamine dextran (70,000 MW; RD; Molecular Probes), and ddH 2 O. Cell Trackerk Green CMFDA (Molecular Probes) was added to seawater at an approximate dilution of 1:10 6 to stain uninjected embryos for transplant experiments. MOs were brought up in sterile water to a concentration of 3 mM and aliquots of 5 Al were frozen at À808C. Immediately before injection, the aliquots were thawed at 658C for 5 min, vortexed, spun down, and aliquoted to the appropriate dilution. The stock was marked and returned immediately to À808C. The diluted MOs were again heated to 658C for 3 min, vortexed, briefly spun down, and left at room temperature. The mRNA for LvN neg or LvN negD were produced from previously described clones (Sherwood and McClay, 1999) . The mRNA was mixed to a final concentration of either 4.5 pg/pL (LvN neg ) or 5.0 pg/pL (LvN negD ) with room temperature NMO. The mixture was injected. The MOs and mRNA mixtures were loaded into pulled injection pipettes and injected into fertilized eggs or twocell stage embryos as described (Mao et al., 1996; Sherwood and McClay, 1999) .
Microsurgery
Both injected and uninjected embryos were rinsed briefly in calcium-free seawater and transferred to a modified Kiehart chamber (Kiehart, 1982) . The embryos were manipulated with two glass needles, one serving as a suction pipette and the other serving as a maneuvering device. In all transplants, the treated embryos were stained red with Rhodamine Dextran, while the control embryos were stained green with Cell Trackerk Green CMFDA (Molecular Probes, Inc.). At the 16-cell stage, micromeres were either removed and discarded or transplanted onto host embryos in defined positions. For transplants, all host micromeres were removed and two donor micromeres were placed at the vegetal pole in their place (McClay et al., 2000) .
Results
Fringe is most closely related to invertebrate Fringe molecules
Fringe was cloned using a combination of PCR and library screens. The conceptually translated protein is 410 amino acids in length (~47 kDa), which is similar to Drosophila Fringe (Irvine and Wieschaus, 1994) and vertebrate Lunatic Fringe (Johnston et al., 1997) . Sequence analysis suggests that Fringe contains a signal sequence for entry into the secretory pathway with a cleavage site at the 33rd amino acid and a dibasic cleavage site at amino acid 110 (data not shown).
The translated Fringe protein was used for phylogenetic analysis along with most identified Fringe molecules. This protein phylogeny suggests that Fringe is most similar to the single-copy Fringe proteins found in the invertebrates Drosophila melanogaster, J. coenia, and S. gregaria ( Fig.  2A) . The protein phylogeny along with the absence of Manic Fringe either in zebrafish and pufferfish genomic sequences (R.E. Peterson, personal observation) further suggests that the Manic Fringe family of proteins is more recently derived.
Fringe mRNA expression remains relatively constant during germ layer development
Northern blot analysis and quantitative PCR (QPCR) establish that fringe mRNA is maternally loaded and present throughout development (Fig. 2B) . QPCR results and Northern blot analysis show a slight and steady decrease in mRNA until the hatched blastula stage, at which time mRNA levels increase through late gastrula stage (Fig. 2C) . Following this mRNA, levels decrease as the pluteus stage is approached.
Mature Fringe appears in multiple locations in the cell
Antibodies against the bacterially expressed Fringe mature peptide were produced in mouse, Guinea pig, and chicken. All antibodies recognized the purified recombinant protein on Western blot analysis (data not shown) and recognize a doublet in Urea-solubilized sea urchin embryos (Fig. 3A) . The apparent molecular weight of about 34 Â 10 3 M r indicates that most Fringe is present in the mature form. Differential solubilization suggests that Fringe is insoluble, being solubilized by 8 M Urea but not by 300 AM NaCl or 1% Triton X-100 (data not shown).
Recent reports demonstrate that Fringe proteins function in the Golgi apparatus (Hicks et al., 2000; Munro and Freeman, 2000) , though other reports suggest that Fringe proteins could be secreted or at the cell surface (Johnston et al., 1997; Ju et al., 2000; Wu et al., 1996) . To determine the sub-cellular distribution of Fringe, early embryos were examined with each of the several antibodies produced against a recombinant mature peptide. With each antibody Fringe staining is detected at the apical membrane (Figs. 3B,C) and as a prominent, central punctate spot of antigen just beneath the apical cell membrane (Figs. 3B,C) . This intracellular spot of antigen was described as the first location where newly glycosylated proteins are seen in the cell (McClay and Wessel, 1984) and presumably represents the trans-Golgi network or a late endosome compartment. Thus, Fringe protein is located both in the Golgi and in surface membranes. Partial affinity purification (Fig. 3D ) and antibody depletion (Fig. 3E ) both provide added support for the specificity of the FNG antibodies.
Fringe expression occurs initially in all cells then becomes restricted during gastrulation
The distribution of Fringe protein was examined throughout development. Antibody to the protein stains all cells at early cleavage stages and this continues until the PMCs lose Fringe at ingression (Fig. 4A) . Shortly thereafter, SMCs lose Fringe, and then, during gastrulation, endoderm cells lose Fringe protein as they invaginate to form the archenteron (Fig. 4B) .
To confirm and better delineate the precise pattern of Fringe expression during morphogenesis, embryos were costained with other antibodies. Notch is lost from SMCs following initial SMC specification and is increased in the adjacent endoderm just before mesenchyme blastula stage, resulting in a torus of Notch expression in the endoderm ( Fig. 4C ; Parks et al., 2000; Sherwood and McClay, 1997 ; summarized in Fig. 1 ). An SMC-specific antibody, SMC-1, recognizes some or all SMCs in the vegetal plate before they ingress (Sweet et al., 1999) . Embryos triple-labeled with Fringe, Notch, and SMC-1 support the conclusion that Fringe disappears from PMCs as they ingress, but Fringe remains on the SMCs and endoderm until gastrulation (Figs. 4C,D) . These data indicate that all Notch signaling must use Delta prior to ingression of the PMCs since Fringe is present on the entire embryo. The first time endoderm or SMCs become available for signaling through any ligand other than Delta is in the invaginated archenteron.
Loss of Fringe protein causes a decrease in secondary mesenchyme cells and a block to gastrulation
A number of studies demonstrate that Delta and Notch are necessary for SMC specification (McClay et al., 2000; Sherwood and McClay, 1999; Sweet et al., 2002) , and because Fringe is necessary for Notch to receive the Delta signal, we expected that a morpholino to fringe (FMO) would eliminate SMCs. As a control, embryos injected with 300 AM FMO display very little Fringe protein compared to control morpholino (CMO)-injected embryos (Figs. 3F,G) . Injection of 300 AM FMO results in a delay in gastrulation and a loss of delaminating SMCs from the tip of the archenteron (Fig. 5B) . Notch MO leads to the same phenotype (NMO; Fig. 5C ) (Sherwood and McClay, 1999; Sweet et al., 2002) . At 600 AM, CMO embryos continue to appear normal, while in embryos injected with FMO or NMO, red pigment cells and invagination of the archenteron are lost or greatly reduced (Figs. 5E-F) . To quantify the loss of pigment cells, CMO, NMO, and FMO were injected on three separate occasions and the number of pigment cells determined 48 h later. The results show a significant decrease in pigment cell number with FMO and NMO compared to CMO injection (Fig. 6 ). These data support the conclusion that absence of Fringe results in a great reduction of SMCs.
The two concentrations of FMO used (600 AM and 300 AM) have highly reproducible, yet different effects on gastrulation. Embryos injected at the 600 AM level fail to gastrulate (Fig. 5E ), while those injected at 300 AM gastrulate after a significant delay but fail to complete this process (Fig. 5H) . Several markers were examined to determine if endoderm specification is blocked in the 600 AM-injected eggs. Endo-1, an endoderm marker, is expressed at the vegetal plate in embryos injected with 600 AM of FMO (Figs. 8B) , as is apical Notch (Fig. 9B) . As described above, apical Notch is present only in the presumptive endoderm and remains there throughout gastrulation. Thus, at least two markers normally found on specified endoderm continue to be expressed.
Loss of Fringe delays ectoderm patterning
FMO-injected embryos (300 Am; Fig. 5H ) also differ from NMO-perturbed embryos by failing to form skeletal barmsQ. Chimeric analyses were performed to determine whether FMO injection affects the PMCs themselves or the overlying ectoderm. Micromeres were swapped between uninjected controls (Figs. 7A,B) and FMO-injected embryos (Figs. 7C,D) . Micromeres bearing FMO produced PMCs that made a normal skeleton after being combined with micromereless control hosts (Figs. 7E,F; n = 24). Reciprocally, normal micromeres produce a normal skeleton when placed on a micromereless host injected with FMO, although the appearance of arms is delayed (Figs. 7G,H; n = 20). Thus, the defect in skeletal arm formation is not due to a Fringe-related failure in PMCs, but to a delay in the overlying cells of the embryo to provide adequate patterning information. Evidence from previous studies showed that positional information from the ectoderm is necessary for the patterning of skeletogenesis (Armstrong and McClay, 1994; Armstrong et al., 1993) , and the PMCs initially form a ring at inside the boundary of the endoderm and ectoderm. Thus, another consequence of Fringe perturbation is the delay in cells in this region to provide the correct signals for skeletogenesis to proceed normally.
To ask if consequences of Fringe perturbations alter ectoderm specification, markers of ectoderm specification were examined. EctoV normally is expressed in all cells of the epithelium until the gastrula stage, at which point the labeling continues to be expressed in the oral ectoderm, stomodeum, and foregut, but is lost from aboral ectoderm and the remaining parts of the endoderm (McClay and Wessel, 1984; Fig. 8C) . In 600 AM FMOinjected embryos, the EctoV staining is reduced but not lost from the aboral region indicating at a delay or Fig. 6 . Pigment cell counts. Pigment cells were counted at 48 h in thirty embryos injected with CMO, FMO, or NMO. Three separate tests were conducted and the SD determined for each thirty-sample set. abnormal oral-aboral specification (Fig. 8D) . The UH-295 monoclonal antibody stains the ciliary band separating the oral and aboral ectoderm compartments. In control embryos, the ciliary band is stained as expected (Fig. 8E ), but in 600 AM FMO-injected embryos, UH-295 expression expands to cover more ectoderm in the most severe cases or is delayed in forming a ciliary band in less severe cases (Fig. 8F) . Both markers indicate a failure to specify oral and aboral ectoderm in the normal time, but the results of Fig. 7 indicate that correct oralaboral patterning information is provided to PMCs.
Previous studies showed that Notch signaling has an impact on specification at the endoderm/ectoderm boundary (Sherwood and McClay, 2001 ). Since loss of Fringe delayed ectoderm patterning, we next examined whether the Fringe effect on ectoderm might be due to some modification of the boundary. As a marker for ectoderm/ endoderm boundary formation, nuclear h-catenin delineates the endodermal side of the boundary ( Fig. 9E ; Sherwood and McClay, 2001) . SoxB1 is retained by ectoderm cells as they are specified and thus was used as an additional marker ( Fig. 9E ; Kenny et al., 1999; Angerer and Angerer, 2003) . Injection of FMO results in a decrease in SoxB1 expression throughout the embryo (Fig. 9B) unlike the pattern seen in CMO-injected controls (Fig. 9A) . Specification of PMCs appears normal. Injection of FMO at the two-cell stage allows visualization of the effect with a control vs. experimental half in the same embryo. The FMO-injected half-embryo fails to gastrulate (Fig. 9D) , fails to retain the SoxB1 protein in the animal half (Fig. 9F) , and appears to lose any sign of an ectoderm-endoderm boundary on the injected side (Fig.  9F) . Though details of the ectoderm gene regulatory network are not known, Notch signals relying on Fringe appear necessary. The thickened cells on the injected side suggest also a slow down in the division of the cells on the side injected with morpholino. The Fringe MO phenotype is different from the published phenotypes reported using dominant-negative Notch expression (Sherwood and McClay, 1999) , in that endoderm, and at the higher concentration, ectoderm, are affected in addition to SMC specification. In an earlier report, a Delta MO was shown to partially block SMC specification but had no apparent effect on endoderm invagination (Sweet et al., 2002) . Given these data, either the Fringe-MO knockdown was more complete than either the Delta or Notch perturbations or Fringe somehow interfered with processes beyond the known Notch modifications. To address this issue, we asked if a more complete Notch knockdown approached the Fringe-MO phenotype. Accordingly, we asked if a combination of injections using 300 AM NMO and dominant-negative notch mRNA would have a more severe phenotype than the NMO alone. Compared to control embryos (Fig. 10A ), embryos injected with either NMO alone (Fig. 10B ) or NMO and a notch control mRNA (Fig.  10C ) display a slight delay in gastrulation and a nearly normal pluteus that lack pigment cells (Figs. 10F,G) . However, injection of NMO and dominant-negative notch mRNA together causes a more severe blockage of gastrulation (Fig. 10D) , from which most embryos do not recover (Fig. 10H) . Thus, a more complete Notch knockdown phenocopies the Fringe-MO embryos.
Discussion
Mesoderm in the sea urchin is specified in the most vegetal region, endoderm is specified above, and ectoderm specification occurs throughout the animal half of the embryo (Angerer and Angerer, 1997; Logan and McClay, 1997) . The Notch signaling pathway is involved in specification decisions that first separate the SMCs from endomesoderm and then in the separation of two different SMC populations (Sherwood and McClay, 1999; Sweet et al., 2002) . Data from this and other studies also suggest that a Notch signal, requiring Fringe, is involved in endoderm specification and in boundary formation between the ectoderm and endoderm Sherwood and McClay, 2001 ). Other earlier studies may Fringe protein is expressed at the cell surface until the onset of morphogenesis A mouse monoclonal and several polyclonal antibodies from chicken and guinea pig were produced to examine the expression of Fringe. The antibodies all recognize the recombinant protein, give the same staining pattern on immunoblots of endogenous protein or of expressed protein, and at a molecular weight predicted from the sequence information (Fig. 3) . Affinity purification and protein preabsorption of the chicken polyclonal antibodies support their specificity (Fig. 3) , and a morpholino to Fringe largely eliminates the Fringe staining. The antibodies stain both a trans-Golgi network compartment and the membrane supporting its role as a glycosyltransferase that modifies Notch. Fringe initially is expressed by all cells of the embryo but disappears from cells as they undergo morphogenesis. Fringe disappears from the SMCs where Notch has signaled shortly before primary invagination of the archenteron. Notch itself disappeared from these areas earlier (Sherwood and McClay, 1997) . Fringe later disappears from endoderm as it invaginates, though in endoderm Notch remains on the cell surface.
Fringe is required for SMC specification
Experiments using FMO injection in comparison with NMO and CMO injections verify that Fringe-modified Notch is necessary for the specification of SMCs. Without Fringe, there is an almost complete loss of pigment cells and of delaminating cells from the tip of the invaginating archenteron (Fig. 5) , well-documented features of SMC-less embryos. The few remaining pigment cells may be due to an extended presence of maternal Fringe protein, and this is supported by the antibody staining from FMO injections in which small amounts of Fringe remain on cells (Fig. 3G) . Since Fringe-modified Notch is imperative for signaling through Delta and a normal Delta signal is produced by the micromeres, this signal cannot be transduced when zygotic Fringe is unavailable to glycosylate Notch in the FMO-injected embryos.
Archenteron invagination requires a Fringe-modified Notch signal Sherwood and McClay (2001) , Sweet et al. (2002) , and Davidson et al. (2002) suggest that a Notch-Delta signal plays some role in the specification of endoderm. However, neither injection of dominant-negative Notch mRNA (Sherwood and McClay, 1999) nor Delta MO injections (Sweet et al., 2002) result in a significant loss of endoderm. Our data show that loss of Fringe also does not completely block endoderm specification, since several protein markers are still expressed (Figs. 8A,B,  9A,B) , but the archenteron fails to invaginate and complete its morphogenesis. The failure to invaginate is a more severe phenotype than that which occurs with injection of Notch dominant-negative alone or NMO alone. Sweet et al. (2002) describe their Delta-MO knockdown as being incomplete even when they used very high concentrations of morpholino (about 6 times higher than the highest concentration of FMO used). The FMO phenotype was matched when maternal and zygotic Notch were perturbed simultaneously (Fig. 10) . Together, these data suggest that the Fringe phenotype demonstrates a requirement for a Notch-Delta signal both for SMC specification and for later endoderm specification prior to morphogenesis. Delayed specification of ectoderm is likely an indirect consequence of loss of Notch signaling
Fringe is expressed throughout the ectoderm, which means that Delta would have to serve as the ligand if Notch were to be activated there (Serrate cannot be activated by Fringe-modified Notch). However, Delta is never expressed directly in, or adjacent to, the ectoderm (Sweet et al., 2002) . Thus, Notch is not activated directly in the ectoderm, in part since the low initial levels of Notch found in the ectoderm eventually disappear (Sherwood and McClay, 1997) , and because Fringe is expressed throughout the ectoderm, Notch cannot signal through Serrate (Serrate-like sequences are in the sea urchin genome, but because of the way Fringe functions, Serrate could not signal in ectoderm even if present in that location). How then might the double Notch perturbations and the Fringe morpholino delay ectoderm specification and/or patterning? The data of Hfrstadius and Wikramanayake and others (Horstadius, 1939; Wikramanayake and Klein, 1997; Wikramanayake et al., 1995) show that a signal from the veg1 layer is required for oral/aboral segregation in the ectoderm. Data from this laboratory show that veg1 is at least partially patterned by a signal from veg2 . Thus, the likely possibility is that the vegetal signal required for oral/aboral specification is delayed, resulting in a large delay in oralaboral patterning, though that patterning eventually occurs. It is also possible that Fringe in the ectoderm normally modifies another protein, but recorded activities of Fringe in every system studied so far are restricted to Notchrelated signaling.
The sea urchin relies on a cascade of signals beginning at the vegetal pole and working towards the animal pole, cellby-cell (Davidson, 1989; Davidson et al., 1998) . The results presented here and the results of others show that Notch activation functions at several important junctures, and these result in SMC specification, and later in endoderm specification necessary for primary invagination of the archenteron. Careful analysis of Notch activation and other Notch modifiers will be necessary to determine more precisely the sequence of specification events that result from each of these Notch-impacted developmental events. Of importance, the Fringe data show that Notch-Delta is responsible for a broad suite of developmentally significant specification events, which reinforces its position high in the specification sequence.
